Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Champions Oncology (CSBR) Return on Capital Employed (2016 - 2026)

Champions Oncology has reported Return on Capital Employed over the past 16 years, most recently at 0.3% for Q1 2026.

  • Quarterly results put Return on Capital Employed at 0.3% for Q1 2026, down 108.0% from a year ago — trailing twelve months through Jan 2026 was 0.3% (down 108.0% YoY), and the annual figure for FY2025 was 0.85%, up 169.0%.
  • Return on Capital Employed for Q1 2026 was 0.3% at Champions Oncology, down from 0.26% in the prior quarter.
  • Over the last five years, Return on Capital Employed for CSBR hit a ceiling of 0.78% in Q1 2025 and a floor of 1.72% in Q1 2024.
  • Median Return on Capital Employed over the past 5 years was 0.13% (2024), compared with a mean of 0.27%.
  • Biggest five-year swings in Return on Capital Employed: plummeted -153bps in 2024 and later soared 250bps in 2025.
  • Champions Oncology's Return on Capital Employed stood at 0.01% in 2022, then crashed by -8104bps to 1.16% in 2023, then surged by 89bps to 0.13% in 2024, then surged by 307bps to 0.26% in 2025, then crashed by -216bps to 0.3% in 2026.
  • The last three reported values for Return on Capital Employed were 0.3% (Q1 2026), 0.26% (Q4 2025), and 0.31% (Q3 2025) per Business Quant data.